Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.
Latest from Tom Gallen
Consumers in Denmark no longer need a prescription to buy opioid antagonist naloxone as the country looks to tackle the growing issue of overdose.
A round-up of recent consumer health appointments: PharmaSGP names new CEO; Stada appoints Vietnam head; NèreS adds to board.
Stada will ship a wide range of consumer healthcare products from its new Romanian production facility, into which the German firm has invested over €70m.
Focusing on the transitional elements of hormone health, marketing dietary supplements to women going through perimenopause and menopause, Health & Her has been acquired by UK-based Venture Life.
Haleon highlighted consistent market share gains in China as it reported third-quarter results.
Dietary supplement ingredient promising enhanced memory and mental clarity marketed widely across the US has been authorized for sale in Europe.